USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Imr+e Corpon
Address:
130 Fifth Avenue North
Seattle, WA 98109
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $222,424.00 5

Award List:

THE OBJECTIVE OF THE PROPOSED RESEARCH IS TO DEVELOP AN IMMUNOLOGICALLY SPECIFIC ADSORBENT FOR USE IN EXTRACORPOREALSYSTEMS TO REMOVE IMMUNOREACTIVE IGM FROM THE SERUM OF PATIENTS FOR PRIMARY BILIARY CIRRHOSIS (PBC).

Award Year / Program / Phase:
1983 / SBIR / Phase I
Award Amount:
$26,704.00
Agency:
HHS
Principal Investigator:
Joseph p. balint jr. , PRINCIPAL INVESTIGATOR
Abstract:
The objective of the proposed research is to develop an immunologically specific adsorbent for use in extracorporealsystems to remove immunoreactive igm from the serum of patients for primary biliary cirrhosis (pbc). by standard immunologic techniques, antibodies to human igm will be isolated. these… More

SEVERAL RECENT REPORTS SUGGEST THAT EXTRACORPOREAL PERFUSION OF TUMOR BEARING PLASMA OVER PROTEIN A CONTAINING SUBSTRATES CAN RESULT IN OBJECTIVE TUMOR REGRESSION IN THE HOST.

Award Year / Program / Phase:
1984 / SBIR / Phase I
Award Amount:
$45,720.00
Agency:
HHS
Principal Investigator:
Joseph p. balint jr. , DIRECTOR
Abstract:
Several recent reports suggest that extracorporeal perfusion of tumor bearing plasma over protein a containing substrates can result in objective tumor regression in the host. in the present investigation, purified staphylococcal protein a is isolated, coupled to an inert biocompatible silica… More
Abstract:
We have reported that extracorporeal immunoadsorption to remove circulating immune complexes (cic) and igg results in complete regression of feline lymphosarcoma, clearance of persistant feline leukemia virus infection and histologic changes associated with improvement in kaposi's sarcoma (ks) in… More

A SERIES OF FUCOSYLATED GLYCOSPHINGOLIPIDS WITH THE ""X'' DETERMINANT (GAL 1 4FUC 1 3GLCNAC) HAVE BEEN SHOWN TO ACCUMULATE IN HUMAN COLONIC AND LIVER ADENOCARCINOMA AND ARE VIRTUALLY ABSENT IN NORMAL COLONIC MUCOSA AND NORMAL LIVER TISSUE.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Anil k. singhal , PRINCIPAL INVESTIGATOR
Abstract:
A series of fucosylated glycosphingolipids with the ""x'' determinant (gal 1 4fuc 1 3glcnac) have been shown to accumulate in human colonic and liver adenocarcinoma and are virtually absent in normal colonic mucosa and normal liver tissue. however, small quantities of fucolipids with the ""x''… More

EASIER TO CONJUGATE TO ANTIBODIES WITH HIGHER REPRODUCIBILITY.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Harry w. snyder, jr. , PRINCIPAL INVESTIGATOR
Abstract:
Easier to conjugate to antibodies with higher reproducibility.the aim of this research is to isolate and characterize antigens in circulating immune complexes (cic) from patients with acquired immunodeficiency syndrome and kaposi's sarcoma (aids-ks) and to exploit these antigens for development of… More